Understanding the mechanisms of postoperative cognitive dysfunction in chronic kidney disease patients

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Patients with chronic kidney disease (CKD) often encounter cardiovascular complications, most commonly coronary heart disease.

Although coronary artery bypass grafting is an effective treatment for this condition, many patients experience cognitive dysfunction after cardiac surgery. The complex interactions among functional status, general anesthesia, cardiopulmonary bypass, and surgical trauma in patients with CKD elevate the risk of neurological issues and increase the mortality rates after surgery. Consequently, both quality of life and overall prognosis are significantly affected.

By reviewing recent research on postoperative cognitive dysfunction in patients with CKD, the authors of this article sought to clarify the underlying mechanisms affecting this population and gain theoretical insights to help decrease perioperative CKD occurrence.

Source:
Journal reference:

Du, J., et al. (2025). Chronic Kidney Disease and Cognitive Dysfunction after Cardiac Surgery. Cardiovascular Innovations and Applications. doi.org/10.15212/cvia.2024.0068.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research links kidney dysfunction to muscle weakness in myotonic dystrophy type 1